转移性结直肠癌中医诊疗指南

Guidelines for Traditional Chinese Medicine Diagnosis and Treatment of Metastatic Colorectal Cancer

结直肠癌是最常见的消化道恶性肿瘤之一。2020年全球新增结直肠癌患者193万例,居全球发病谱第三位,新增死亡病例93万例,居全球死因谱第二位。同时,转移性结直肠癌的医疗费用是所有分期中最高的。已有大量研究表明中医治疗可为转移性结直肠癌患者带来临床获益,且疗效独特。为进一步规范转移性结直肠癌的中医诊疗方案,提高其中医诊治水平,中国中医科学院西苑医院联合全国相关单位,根据《世界卫生组织指南制定手册》的指南制定流程和《基于证据体的中医药临床证据分级标准》《中华中医药学会团体标准管理办法》等相关要求,结合中医诊疗特色及我国实际情况,按照既往国家中医药管理局医政司发布的《24个专业105个病种中医诊疗方案目录》,制定了《转移性结直肠癌中医诊疗指南》。

Colorectal cancer is one of the most common malignant tumors of digestive tract.In 2020,1.93 million new cases of colorectal cancer were diagnosed globally,ranking third in the global incidence spectrum,and 930000 new deaths were reported,ranking second in the global cause of death spectrum.Meanwhile,the medical cost of metastatic colorectal cancer is the highest among all stages.A large number of studies have demonstrated that traditional Chinese medicine(TCM)treatment can bring clinical benefits to patients with metastatic colorectal cancer with unique efficacy.In order to further standardize the TCM diagnosis and treatment for metastatic colorectal cancer and improve the level of TCM diagnosis and treatment,Xiyuan Hospital,China Academy of Chinese Medical Sciences,together with other relevant units in China,according to the guideline development process of the World Health Organization Handbook for Guideline Development and the relevant requirements of the Clinical Evidence Grading Criteria on TCM Based on Evidence Body,the Regulations for Group Standards of China Association of Chinese Medicine and others,combined with the characteristics of TCM diagnosis and treatment and the actual situation in China,the Guidelines for TCM Diagnosis and Treatment of Metastatic Colorectal Cancer was developed in accordance with the Catalogue of TCM Diagnosis and Treatment Plans for 105 Diseases in 24 Specialties issued by Department of Medical Administration of National Administration of TCM.